THE SCHWARTZ SCORE – DETAILED EXPLANATION
1. QTc Duration
QT prolongation is the most heavily weighted parameter because delayed ventricular repolarization predisposes patients to polymorphic ventricular tachycardia, particularly torsades de pointes.
• QTc ≥ 480 ms → 3 points
• QTc 460–469 ms → 2 points
• QTc 450–459 ms (males) → 1 point
2. ECG Features
• Torsades de pointes → 2 points
• T-wave alternans → 1 point (marker of repolarization instability)
• Notched T waves in ≥3 leads → 1 point (seen particularly in LQT2)
• Low heart rate for age → 0.5 point
3. Clinical History
• Syncope WITH stress/emotion/exercise → 2 points
• Syncope WITHOUT stress → 1 point
Syncope in LQTS is typically arrhythmic rather than vasovagal, often occurring during exertion (LQT1), auditory triggers (LQT2), or rest/sleep (LQT3).
4. Family History
• First-degree relative with definite LQTS → 1 point
• Unexplained sudden cardiac death <30 years → 0.5 point
A cumulative score >3 indicates high probability of congenital LQTS.
TYPES OF LONG QT SYNDROME (GENOTYPIC AND PHENOTYPIC PATTERNS)
Type 1 – LQT1
• Mutation: KCNQ1 (IKs channel)
• Triggers: Exercise, especially swimming
• ECG: Broad-based T waves
• Risk: Highest risk with exertion
Type 2 – LQT2
• Mutation: KCNH2 (IKr channel)
• Triggers: Sudden loud noises, emotional stress
• ECG: Low-amplitude, notched T waves
• Risk: High risk in postpartum women
Type 3 – LQT3
• Mutation: SCN5A (sodium channel gain-of-function)
• Triggers: Rest, sleep
• ECG: Long isoelectric ST segment
• Risk: Event risk at night; slower heart rates worsen QT
Other Types (LQT4–LQT13)
Less common, involving calcium channels, ankyrin B, and other ion-channel regulatory proteins, each presenting with variable risk profiles.
ACQUIRED LONG QT SYNDROME
Most common form, due to:
• Drugs: antiarrhythmics (Class Ia/III), macrolides, quinolones, antipsychotics, antidepressants
• Electrolyte abnormalities: hypokalemia, hypomagnesemia, hypocalcemia
• Bradycardia or AV block
• CNS events (stroke, subarachnoid hemorrhage)
MANAGEMENT OF LONG QT SYNDROME
1. Lifestyle & Trigger Avoidance
• Avoid QT-prolonging medications (crediblemeds.org list)
• Correct electrolytes aggressively
• Avoid strenuous swimming (LQT1)
• Avoid sudden auditory alarms (LQT2)
• Avoid bradycardia-inducing states (LQT3)
2. Pharmacologic Therapy
Beta Blockers – cornerstone in congenital LQTS
• Preferred: Nadolol or Propranolol
• Reduce risk of arrhythmic events significantly
Particularly effective in LQT1 and LQT2; less so in LQT3.
Mexiletine (for LQT3)
• Shortens QT by reducing late sodium current
• Useful adjunct when bradycardia worsens QT prolongation
Potassium Supplementation
• Helps shorten QT in some forms
3. Device Therapy
Implantable Cardioverter-Defibrillator (ICD) indicated when:
• Survivors of cardiac arrest
• Recurrent syncope or arrhythmias despite maximal beta-blocker therapy
• Very high-risk genotypes, especially those with markedly prolonged QTc
4. Left Cardiac Sympathetic Denervation (LCSD)
Considered when:
• Beta-blockers not tolerated or inadequate
• ICD shocks are frequent
• Particularly effective for LQT1 and LQT2
5. Management of Acute Torsades de Pointes
• IV magnesium sulfate (first-line)
• Stop offending agents
• Correct K+, Mg2+, Ca2+
• Overdrive pacing or isoproterenol for bradycardia-induced TdP
• Temporary pacing to maintain HR 90–110 bpm if needed
CLINICAL PEARLS
• A QTc >500 ms is the strongest predictor of torsades risk.
• LQT1 events typically occur during exercise; LQT2 with emotional/auditory triggers; LQT3 at rest.
• In congenital LQTS, beta-blockers are lifelong therapy even in asymptomatic individuals.
• Avoid QTc measurement during abnormal T-U fusion; use tangent method for accuracy.

Comments
Post a Comment
Drop your thoughts here, we would love to hear from you